These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1864717)

  • 1. Induced priapism and its management.
    Török A; Jilling A; Götz F
    Int Urol Nephrol; 1991; 23(2):191-4. PubMed ID: 1864717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metaraminol--an antidote in corpus cavernosum autoinjection therapy-induced prolonged erection].
    Stief CG; Gilbert P; Wetterhauer U; Bähren W; Thon W; Altwein JE
    Urologe A; 1986 May; 25(3):164-5. PubMed ID: 2426857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Papaverine-induced priapism. Experiences with a new urologic emergency].
    Schneider AW; Busch R; Gonnermann D; Klosterhalfen H
    Dtsch Med Wochenschr; 1989 Feb; 114(6):214-7. PubMed ID: 2917481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged erections following intracorporeal injection of medications to overcome impotence.
    Watters GR; Keogh EJ; Carati CJ; Earle CM; Wisniewski ZS; Tulloch AG; Lord DJ
    Br J Urol; 1988 Aug; 62(2):173-5. PubMed ID: 3408889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Priapism following intracavernous injection of vasoactive substances as a urologic emergency].
    Papadopoulos I; Weichert-Jacobsen K; Wand H
    Z Urol Nephrol; 1990 May; 83(5):233-7. PubMed ID: 2392883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of drug-induced priapism].
    Török A; Jilling A; Götz F
    Orv Hetil; 1991 Mar; 132(12):633-4. PubMed ID: 2011386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Priapism induced by intracavernous injection].
    Morales Concepción JC
    Arch Esp Urol; 1992 Oct; 45(8):793-5. PubMed ID: 1466580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risks of self-injection therapy for impotence.
    Millard RJ; Stricker PD; Lynch WJ; Dean TE; Murnaghan GF; Breslin FH
    Med J Aust; 1996 Jul; 165(2):117-8. PubMed ID: 8692055
    [No Abstract]   [Full Text] [Related]  

  • 9. Emergency treatment of papaverine priapism.
    Fernandez JA; Basha MA; Wilson GC
    J Emerg Med; 1987; 5(4):289-91. PubMed ID: 3624835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nocturnal computed rigidity and tumescence evaluation in the prevention of the iatrogenic priapism.
    Quadraccia A; Salvini A; Cordani C; Pizzi P; Bellinzoni G
    Acta Urol Belg; 1988; 56(2):226-31. PubMed ID: 3400529
    [No Abstract]   [Full Text] [Related]  

  • 11. How safe is the treatment of impotence with intracavernous autoinjection?
    Zentgraf M; Ludwig G; Ziegler M
    Eur Urol; 1989; 16(3):165-71. PubMed ID: 2663519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological priapism: comparison of trazodone- and papaverine-associated cases.
    Bardin ED; Krieger JN
    Int Urol Nephrol; 1990; 22(2):147-52. PubMed ID: 2354895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Priapism: an avoidable complication of pharmacologically induced erection.
    Fouda A; Hassouna M; Beddoe E; Kalogeropoulos D; Binik YM; Elhilali MM
    J Urol; 1989 Oct; 142(4):995-7. PubMed ID: 2795759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical treatment of impotence with papaverine and phentolamine intracavernosal injection.
    Dinsmore WW
    Ulster Med J; 1990 Oct; 59(2):174-6. PubMed ID: 2278115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Priapism as a complication of the treatment of impotence by local injections of papaverine].
    Kaczmarek A
    Wiad Lek; 1990 Sep 1-15; 43(17-18):908-10. PubMed ID: 2278150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Side effects of self-administration of intracavernous papaverine and phentolamine for the treatment of impotence.
    Levine SB; Althof SE; Turner LA; Risen CB; Bodner DR; Kursh ED; Resnick MI
    J Urol; 1989 Jan; 141(1):54-7. PubMed ID: 2908954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Priapism associated with concurrent use of phosphodiesterase inhibitor drugs and intracavernous injection therapy.
    McMahon CG
    Int J Impot Res; 2003 Oct; 15(5):383-4. PubMed ID: 14562142
    [No Abstract]   [Full Text] [Related]  

  • 18. Physiology of erection and pharmacological management of impotence.
    Lue TF; Tanagho EA
    J Urol; 1987 May; 137(5):829-36. PubMed ID: 3553617
    [No Abstract]   [Full Text] [Related]  

  • 19. Injection therapy for impotence.
    Kursh ED; Bodner DR; Resnick MI; Althof SE; Turner L; Risen C; Levine SB
    Urol Clin North Am; 1988 Nov; 15(4):625-9. PubMed ID: 3055615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of a mixture of papaverine, phentolamine and prostaglandin E1 with other intracavernous injections.
    Meinhardt W; Lycklama à Nijeholt AA; Kropman RF; Vermeij P; Zwartendijk J
    Eur Urol; 1994; 26(4):319-21. PubMed ID: 7713130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.